![Robert Jacks](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Robert Jacks was the founder of Symbiomix Therapeutics LLC, founded in 2012, holding the title of President & Chief Financial Officer.
Mr. Jacks is currently the President, Chief Executive Officer & Director at Sparrow Pharmaceuticals, Inc. since 2021.
Former positions include President, Chief Executive Officer & Director at Indalo Therapeutics, Inc., Principal at Pfizer Inc., Vice President-Business Development at Paramount BioSciences LLC, and Vice President & Head-Development at ACT Biotech, Inc. Education includes an undergraduate degree from Duke University, a graduate degree from Stanford University, and an MBA from Columbia Business School.
| Unternehmen | Position | Beginn |
|---|---|---|
Sparrow Pharmaceuticals, Inc.
 Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Vorstandsvorsitzender | 01.01.2021 |
| Unternehmen | Position | Ende |
|---|---|---|
Indalo Therapeutics, Inc.
 Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Vorstandsvorsitzender | - |
Symbiomix Therapeutics LLC
 Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Gründer | - |
ACT Biotech, Inc.
 ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Corporate Officer/Principal | - |
| PFIZER INC. | Corporate Officer/Principal | - |
Paramount BioSciences LLC
 Paramount BioSciences LLC Investment ManagersFinance Paramount invests in companies located in the United States. The firm focuses on companies operating in the fields of biotechnology, pharmaceutical development, healthcare and life-sciences sectors. | Private Equity Investor | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
| Private Unternehmen | 9 |
|---|---|
Pfizer Inc.
 Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
Symbiomix Therapeutics LLC
Symbiomix Therapeutics LLC BiotechnologyHealth Technology Develops medicines for prevalent gynecologic infections | Health Technology |
Duke University
 Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paramount BioSciences LLC
Paramount BioSciences LLC Investment ManagersFinance Paramount invests in companies located in the United States. The firm focuses on companies operating in the fields of biotechnology, pharmaceutical development, healthcare and life-sciences sectors. | Finance |
ACT Biotech, Inc.
ACT Biotech, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes targeted oral cancer drugs | Health Technology |
Columbia Business School
 Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Indalo Therapeutics, Inc.
Indalo Therapeutics, Inc. BiotechnologyHealth Technology Develops therapies for fibrotic diseases | Health Technology |
Sparrow Pharmaceuticals, Inc.
Sparrow Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen
